Director Of Pricing Policy And Analytics

Ascendis Pharma is a fast-growing biopharmaceutical company with locations in Denmark, United States, Germany, United Kingdom, Italy, Spain, and France. Guided by our core values of Patients, Science, and Passion, we are applying our innovative TransCon technology platform to build a leading, fully integrated biopharmaceutical company. We have a diverse pipeline designed to make a meaningful difference for patients. We have started to launch our Endocrinology Rare Disease portfolio globally, in the US, Germany & Austria, with plans for rapid expansion.

As our new Director Of Pricing Policy And Analytics, you will be evaluating the impact of policy on pricing and developing an advanced analytics arm for the Pricing & Contracting team within the US, Ascendis' largest affiliate.

You will report directly to the Sr. Director, Pricing & Contracting Strategy and be based in Princeton, NJ. This opportunity is based upon a hybrid model with an expectation of three days each week in-office for coordination and collaborative purposes.

This role will have three main areas of focus:

1. Evaluate policy impact on pricing strategies and policies that align with the company's business objectives and regulatory compliance, and impact market dynamics for our leading products in the US Market
2. Develop and design data-driven pricing dashboards and analytical models in response to the evolving U.S. healthcare reimbursement environment to inform executive-level insights and decision-making for in-line and pipeline assets.
3. Benchmark and develop analogs for pricing strategies across therapeutic areas and track payer and PBM behavior, formulary decisions, and contract performance to inform pricing tactics

You will be responsible for:

• Oversee the development and application of advanced analytics models to evaluate price elasticity, scenario modeling, and value-based pricing strategies.
• Use claims data and forecasting tools to inform pricing decisions and reimbursement strategies.
• Monitor and evaluate policy developments (e.g., CMS reforms, IRA, international reference pricing) and their potential impact on pricing and access strategies.
• Lead the refinement of pharmaceutical pricing policies in alignment with commercial, legal, and market access strategies.
• Collaborate with Market Access, Government Affairs, Legal, Regulatory, Finance, and Commercial teams to ensure pricing policies are consistent, competitive, and compliant.
• Benchmark pricing strategies across therapeutic areas and geographies.
• Track payer and PBM behavior, formulary decisions, and contract performance to inform pricing tactics.

Your key stakeholders will be:

• US Market Access and Patient Services
• US Government Affairs
• Finance and Government Pricing
• Legal and Compliance